Torrent Pharma's Net Profit Surges 14% YoY In Q3FY23

Torrent Pharmaceuticals, the Indian pharma major headquartered in Ahmedabad on Wednesday announced its consolidated financial results for the third quarter that ended 31st December 2022, the pharmaceutical company registered a 18 per cent rise in its consolidated revenues year on year

Torrent Pharma's Gujarat Facility Gets OAI Status From USFDA

The manufacturing site was first inspected on September 28, 2022, and was issued Form 483 with three observations by the top US Health regulator flagging quality as well as procedural lapses at the facility

Torrent Pharma Reports Sales Of Rs 2,291 Cr, PAT Down By 1% YoY In Sept Quarter

The pharma company’s net profit slumped by 1 per cent year on year (YoY) and stood at Rs 312 crores in the second quarter from Rs 316 crores in the previous year

Torrent Pharma Q1 Net Profit Up 2.8 % To Rs 330 Cr

Consolidated revenue from operations of the company stood at Rs 2,134 crore for the quarter under consideration. It was Rs 2,056 crore for the same period a year ago

Torrent Pharma Shares Zoom 13% After Q1 Earnings

The scrip jumped 13.05 per cent to Rs 2,754.90 -- its one-year high level -- on the BSE.

Ind-Ra Affirms Torrent Pharmaceuticals Long-Term Issuer Rating At AA With Stable Outlook

The pharmaceuticals sector falls under essential services and hence is operational despite the ongoing nation-wide lockdown.

Best CFO Awards 2016-17 | Acquire And Grow

How Ashok Modi planned aggressive growth without stressing the balance sheet

Sun Pharmaceutical Gets US Approval To Buy Ranbaxy

Germany Names 16 Firms In Suspension Of Drugs